...
首页> 外文期刊>The journal of immunology >“Pruning” of Alloreactive CD4+ T Cells Using 5- (and 6-)Carboxyfluorescein Diacetate Succinimidyl Ester Prolongs Skin Allograft Survival
【24h】

“Pruning” of Alloreactive CD4+ T Cells Using 5- (and 6-)Carboxyfluorescein Diacetate Succinimidyl Ester Prolongs Skin Allograft Survival

机译:使用5-(和6--)羧基荧光素双乙酸酯琥珀酰亚胺酯“修剪”同种异体反应性CD4 + T细胞可延长同种异体皮肤的存活时间

获取原文

摘要

Removal of alloreactive cells by either thymic deletion or deletion/anergy in the periphery is regarded as crucial to the development of tolerance. Dyes, such as CFSE, that allow monitoring of cell division suggest that in vitro proliferation could be a used as a way of “pruning” alloreactive cells while retaining a normal immune repertoire with retention of memory to previously encountered pathogens. This would overcome the problems occurring as a result of therapies that use massive depletion of T cells to allow acceptance of organ transplants or bone marrow grafts. We therefore used a skin graft model of CD4-mediated T cell rejection across a major H-2 mismatch (C57BL/6 (H-2b) to BALB/c (H-2d) mice) to evaluate whether nondividing CD4+ T cells derived from a mixed lymphocyte culture would exhibit tolerance to a skin graft from the initial stimulator strain. We demonstrate that selective removal of dividing alloreactive CD4+ T cells resulted in marked specific prolongation of allogeneic skin graft survival, and that the nondividing CD4+ T cells retained a broad TCR repertoire and the ability to maintain memory. This novel way of depleting alloreactive T cells may serve as a useful strategy in combination with other mechanisms to achieve transplant tolerance.
机译:通过胸腺缺失或外周缺失/无反应去除同种异体反应细胞被认为对耐受性的发展至关重要。可以监测细胞分裂的染料,例如CFSE,表明体外增殖可以用作“修剪”同种反应性细胞的一种方法,同时保留正常的免疫库,并保留对先前遇到的病原体的记忆。这将克服由于大量使用T细胞而允许接受器官移植或骨髓移植的疗法所引起的问题。因此,我们使用跨主要H-2错配(C57BL / 6(H-2b)到BALB / c(H-2d)小鼠)的CD4介导的T细胞排斥的皮肤移植模型来评估是否非分裂CD4 + T细胞来源于混合的淋巴细胞培养物将对初始刺激株产生的皮肤移植物具有耐受性。我们证明选择性去除分裂的同种反应性CD4 + T细胞导致同种异体皮肤移植物存活的明显特异性延长,并且非分裂的CD4 + T细胞保留广泛的TCR组成和维持记忆的能力。消耗同种异体反应性T细胞的这种新颖方法可以与其他机制结合使用,以实现移植耐受性。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号